Supply Chain

The Dublin-based drugmaker Shire is lobbying against several provisions in the Republican's healthcare reform plan, according to CEO Flemming Ornskov, MD.

Two former drug executives at a Tinton Falls, N.J.-based cancer drug distribution company on Friday pled guilty to selling medical supplies contaminated with mold, reports New York Daily News.

The Food and Drug Administration user fee reauthorization bill, which House representatives passed Wednesday, contains a measure that would triple the amount of time device companies have to report product issues, reports Star Tribune.

Here are the three latest drugs or medical devices approved by the Food and Drug Administration this week.

The Food and Drug Administration on Thursday approved Janssen Biotech's psoriasis treatment Tremfya.

Here are seven articles published by Becker's Hospital Review this week, featuring a look into the efficacy of outcomes-based drug pricing contracts, one hospital's unique attempt to attract blood donors and a report on cybersecurity vulnerabilities in industrial robots, among…

 The Food and Drug Administration on Tuesday granted full approval Amgen's biologic drug Blincyto.

The U.S. House of Representatives on Wednesday passed a bill to reauthorize the Food and Drug Administration's user fee program, reports Regulatory Focus.

Outcomes-based drug pricing, which sets drug prices based on how much they improve patients' health, is gaining steam in the U.S. healthcare system. However, many industry stakeholders are skeptical of the methodology, which has few proven benefits, according to a…

The QuintilesIMS Institute recently conducted a study on drug spending composition and evolution in five countries — France, Germany, Japan, U.K. and the United States.